Keyphrases
Prostate-specific Antigen
100%
Radical Prostatectomy
100%
Biochemical Recurrence of Prostate Cancer
100%
Positron Emission Tomography-computed Tomography (PET-CT)
66%
Prostate-specific Antigen Level
50%
Detection Rate
33%
External Beam Radiotherapy
33%
Gleason Score
33%
Androgen Deprivation Therapy
33%
18F-labeled
33%
Large-scale Production
16%
Hybrid Radio
16%
Detection Efficiency
16%
Lymph Node Metastasis
16%
Pelvis
16%
PET Tracer
16%
Consecutive Patients
16%
Pathological Findings
16%
Biochemical Recurrence
16%
Theranostics
16%
Bone Metastasis
16%
Local Recurrence
16%
Recurrent Prostate Cancer
16%
Targeted Agents
16%
Long Half-life
16%
Restaging
16%
Antigen Targeting
16%
Visceral Metastases
16%
Uptake Time
16%
Supradiaphragmatic
16%
Gallium-68
16%
Retroperitoneum
16%
Positron Range
16%
Early Biochemical Recurrence
16%
High Detection Rate
16%
Injected Activity
16%
Medicine and Dentistry
Prostate Cancer
100%
Fluorine-18
100%
Prostatectomy
100%
Biochemical Recurrence
100%
Polyethylene Terephthalate
100%
Prostate Specific Antigen
62%
Prostate Specific Membrane Antigen
50%
Positron Emission Tomography-Computed Tomography
50%
Recurrent Disease
25%
External Beam Radiotherapy
25%
Gallium 68
25%
Gleason Score
25%
Androgen Deprivation Therapy
25%
Lymph Node Metastasis
12%
Pelvis
12%
Bone Metastasis
12%
Visceral Metastasis
12%
Retroperitoneum
12%
Preference
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorine 18
100%
Prostate Cancer
100%
Biochemical Recurrence
100%
Polyethylene Terephthalate
100%
Prostate Specific Antigen
62%
Prostate Specific Membrane Antigen
50%
Recurrent Disease
25%
Gleason Score
25%
Gallium 68
25%
Androgen
25%
Bone Metastasis
12%
Lymph Node Metastasis
12%
Visceral Metastasis
12%
Preference
12%